Iguana Healthcare Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$7.51M |
| 2 |
Bausch Health
BHC
|
+$7M |
| 3 |
McKesson
MCK
|
+$6.36M |
| 4 |
AET
Aetna Inc
AET
|
+$5.78M |
| 5 |
Biogen
BIIB
|
+$4.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ultragenyx Pharmaceutical
RARE
|
+$10.3M |
| 2 |
CELG
Celgene Corp
CELG
|
+$7.45M |
| 3 |
STJ
St Jude Medical
STJ
|
+$7.31M |
| 4 |
ESPR
Esperion Therapeutics
ESPR
|
+$6.28M |
| 5 |
IPCM
IPC HEALTHCARE INC COM DTD
IPCM
|
+$4.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 74.13% |
| 2 | Financials | 2.15% |
| 3 | Consumer Staples | 1.24% |
| 4 | Technology | 0% |
Similar funds
Iguana Healthcare Management's Q3 2015 Portfolio in Review
As of Q3 2015, Iguana Healthcare Management held 95 positions worth $254M, down 20% from $317M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Iguana Healthcare Management withdrew a net $23.6M in Q3 2015, closing 24 positions and reducing 16 holdings. Its most notable exit was St Jude Medical, an estimated $7.31M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 74% of assets, up from 68% a quarter earlier, followed by Financials and Consumer Staples.
Against the trend, Iguana Healthcare Management opened a new position in McKesson worth $5.55M.
- Iguana Healthcare Management's largest Q3 2015 buy was McKesson: 30,000 shares worth $5.55M.
- Iguana Healthcare Management added most to Elevance Health in Q3 2015, an estimated $7.51M increase.
- Iguana Healthcare Management's biggest Q3 2015 reduction was Ultragenyx Pharmaceutical, cutting an estimated $10.3M.
- Iguana Healthcare Management fully exited St Jude Medical in Q3 2015, selling an estimated $7.31M.
- Iguana Healthcare Management's ten largest holdings make up 43% of its $254M portfolio in Q3 2015.
- Iguana Healthcare Management opened 26 new positions and closed 24 in Q3 2015.
- Iguana Healthcare Management's portfolio value fell 20% quarter-over-quarter to $254M.
Based on Iguana Healthcare Management's 13F filing for Q3 2015, filed 16 Nov 2015.